Founders seeking exit value Sequent Scientific at Rs 2,500 crore

Sequent’s market cap as on Tuesday was Rs 1,670 crore. But the founders are seeking a control premium of 49.7% or 18-20x forward Ebitda multiple, valuing the company at Rs 2,100-2,500 crore, sources said. Some, however, worry that such expectations may turn out to be a potential deal breaker.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2OPhFLH
via IFTTT